These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7617006)

  • 1. Screening for colorectal cancer. French Working Group on Colorectal Cancer Screening.
    Dubois G
    N Engl J Med; 1995 Aug; 333(7):460-1. PubMed ID: 7617006
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it time to recommend screening for colorectal cancer?
    Lieberman D; Sleisenger MH
    Lancet; 1996 Nov; 348(9040):1463-4. PubMed ID: 8942770
    [No Abstract]   [Full Text] [Related]  

  • 5. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening: clinical applications.
    Walsh JM; Terdiman JP
    JAMA; 2003 Mar; 289(10):1297-302. PubMed ID: 12633192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications.
    Beswick L; Ting A; Macrae F; Dowling D; Hair C
    Intern Med J; 2014 Dec; 44(12a):1264-5. PubMed ID: 25442767
    [No Abstract]   [Full Text] [Related]  

  • 8. ABC of colorectal cancer: screening.
    Scholefield JH
    BMJ; 2000 Oct; 321(7267):1004-6. PubMed ID: 11039973
    [No Abstract]   [Full Text] [Related]  

  • 9. [Colorectal cancer screening should be evaluated in Swedish studies].
    Blom J
    Lakartidningen; 2008 Sep 17-23; 105(38):2564-7. PubMed ID: 18846858
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nationwide colorectal cancer screening].
    van Rossum LG; Laheij RJ; Jansen JB
    Ned Tijdschr Tandheelkd; 2010 May; 117(5):263-7. PubMed ID: 20506902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer.
    Brock G; Gurekas V
    CMAJ; 2001 Apr; 164(7):966; author reply 967-8. PubMed ID: 11314445
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
    Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
    Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening strategies for colorectal cancer.
    Solomon MJ; McLeod RS
    Surg Clin North Am; 1993 Feb; 73(1):31-45. PubMed ID: 8426996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
    Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
    Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated guidelines call for higher colorectal cancer screening rates.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Apr; 12(7):5-7. PubMed ID: 12075629
    [No Abstract]   [Full Text] [Related]  

  • 17. Which colorectal cancer screening test is best?
    Mandel JS
    J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mass screening for colorectal cancer in France. Experience in 165,000 people in the department of Calvados].
    Launoy G; Herbert C; Vallée JP; Desoubeaux N; Réaud JM; Ollivier V; Bouvier V; Flachs A; Arsène D; Valla A; Gignoux M
    Gastroenterol Clin Biol; 1996; 20(3):228-36. PubMed ID: 8763059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
    Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
    Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [To screen the colorectal cancer. An organized process].
    Chedru MF; Dumont C; Bloch J; Lequellec-Nathan M; Postel-Vinay N; Coquin Y; Dab W
    Rev Prat; 2004 Jan; 54(2):121-2. PubMed ID: 15086052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.